Market Closed -
Canadian Securities Exchange
03:52:57 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
0.025
CAD
|
0.00%
|
|
0.00%
|
-28.57%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
298.7
|
250.9
|
33.7
|
16.3
|
165.3
|
171.9
|
Enterprise Value (EV)
1 |
314.6
|
382.7
|
229
|
231.6
|
334.9
|
359.8
|
P/E ratio
|
-4.15
x
|
-0.77
x
|
-0.11
x
|
-0.21
x
|
-0.19
x
|
-2.22
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
87.7
x
|
3.2
x
|
0.22
x
|
0.08
x
|
1.02
x
|
1.08
x
|
EV / Revenue
|
92.4
x
|
4.88
x
|
1.51
x
|
1.14
x
|
2.06
x
|
2.27
x
|
EV / EBITDA
|
-12.2
x
|
-7.17
x
|
-18.8
x
|
10.6
x
|
-8.44
x
|
-25.1
x
|
EV / FCF
|
-10.1
x
|
-6.08
x
|
7.92
x
|
5.86
x
|
-15
x
|
12.2
x
|
FCF Yield
|
-9.88%
|
-16.4%
|
12.6%
|
17.1%
|
-6.65%
|
8.17%
|
Price to Book
|
2.68
x
|
0.69
x
|
0.66
x
|
-0.73
x
|
15
x
|
-2.79
x
|
Nbr of stocks (in thousands)
|
74,163
|
171,643
|
171,718
|
171,718
|
6,403,482
|
6,510,527
|
Reference price
2 |
4.027
|
1.462
|
0.1963
|
0.0949
|
0.0258
|
0.0264
|
Announcement Date
|
4/12/19
|
7/31/20
|
3/31/21
|
3/17/22
|
3/29/23
|
3/28/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3.405
|
78.38
|
151.7
|
203
|
162.6
|
158.4
|
EBITDA
1 |
-25.7
|
-53.37
|
-12.2
|
21.8
|
-39.67
|
-14.35
|
EBIT
1 |
-32.05
|
-74.58
|
-38.39
|
-7.124
|
-68.76
|
-39.49
|
Operating Margin
|
-941.13%
|
-95.15%
|
-25.31%
|
-3.51%
|
-42.29%
|
-24.93%
|
Earnings before Tax (EBT)
1 |
-62.03
|
-304.3
|
-289.9
|
-54
|
-438.7
|
-59.92
|
Net income
1 |
-62.03
|
-301.3
|
-309.8
|
-76.25
|
-449.4
|
-76.62
|
Net margin
|
-1,821.51%
|
-384.34%
|
-204.29%
|
-37.56%
|
-276.36%
|
-48.36%
|
EPS
2 |
-0.9713
|
-1.904
|
-1.805
|
-0.4440
|
-0.1333
|
-0.0119
|
Free Cash Flow
1 |
-31.07
|
-62.93
|
28.93
|
39.51
|
-22.27
|
29.4
|
FCF margin
|
-912.31%
|
-80.29%
|
19.07%
|
19.46%
|
-13.69%
|
18.56%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
181.21%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/12/19
|
7/31/20
|
3/31/21
|
3/17/22
|
3/29/23
|
3/28/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
15.9
|
132
|
195
|
215
|
170
|
188
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-0.6201
x
|
-2.47
x
|
-16.01
x
|
9.874
x
|
-4.276
x
|
-13.09
x
|
Free Cash Flow
1 |
-31.1
|
-62.9
|
28.9
|
39.5
|
-22.3
|
29.4
|
ROE (net income / shareholders' equity)
|
-93.2%
|
-126%
|
-154%
|
-612%
|
7,105%
|
302%
|
ROA (Net income/ Total Assets)
|
-18.7%
|
-12.1%
|
-5.09%
|
-1.27%
|
-13.3%
|
-8.5%
|
Assets
1 |
331.7
|
2,496
|
6,086
|
5,993
|
3,390
|
901.6
|
Book Value Per Share
2 |
1.500
|
2.130
|
0.3000
|
-0.1300
|
0
|
-0.0100
|
Cash Flow per Share
2 |
0.2100
|
0.2000
|
0.0600
|
0.0800
|
0
|
0
|
Capex
1 |
13.9
|
48.5
|
13.4
|
19.4
|
6.94
|
3.57
|
Capex / Sales
|
408.32%
|
61.92%
|
8.86%
|
9.58%
|
4.27%
|
2.25%
|
Announcement Date
|
4/12/19
|
7/31/20
|
3/31/21
|
3/17/22
|
3/29/23
|
3/28/24
|
|
1st Jan change
|
Capi.
|
---|
| -28.57% | 121M | | +31.96% | 272M | | +33.74% | 261M | | +49.42% | 194M | | +44.98% | 131M | | +115.91% | 119M | | 0.00% | 86.82M | | +150.00% | 75.33M | | +1.20% | 55.24M | | +14.38% | 52.63M |
Medical Farming
|